The position of Chief Scientific Advisor could be dropped under Jean-Claude Juncker’s European Commission, although the EU executive made a U-turn in January and reinstated the role following pressure from Parliament.
Carlos Moedas, the EU Commissioner responsible for Research and Innovation, was asked by Juncker to present a report before the summer outlining how a new chief scientific advisor could work with the EU executive.
Moedas will make recommendations on the background and qualifications the right candidate should possess, an EU official told EURACTIV.
But the EU official, who spoke to EURACTIV on condition of anonymity, did not exclude that the position could be scrapped if no candidate fits the job description.
“I shouldn’t speculate what the report will contain, but generally the Commission President has said that he feels strongly about having an independent scientific advisor at the Commission if we find the right way of instituting this person in the Commission,” the official said.
In 2011, Anne Glover, a Scottish biology professor, was appointed as the EU’s first Chief Scientific Advisor. Glover’s role was to provide independent expert advice on any aspect of science, technology and innovation requested by the President of the European Commission, usually in relation to major policy proposals being submitted to the EU executive.
The role “ceased to exist” as the Barroso II Commission mandate came to an end in November last year, but was later reinstated by the new Commission following pressure from Members of the European Parliament.
Roberto Bertollini, the World Health Organisation’s (WHO) EU Representative and Chief Scientist for Europe, talked up the position last week, saying it remained of crucial importance for the Commission’s decision-making process.
Bertollini said he was worried that the Commission would be unable to take action when presented with strong evidence of health risks, for example, related to air pollution.
“I think this is where we need to say that the public needs to have confidence in authorities. When faced with strong evidence and actions are not taken or there is a slow pace, then the confidence of the public decreases. Then you open the space to this wave of scepticism and populism which can create a lot of problems,” the WHO representative said.
He mused whether the current vacancy was responsible for the delayed legislation related to health and food safety.
The reason why Glover had to leave the Commission remains unclear. In an interview with the BBC’s Hardtalk programme in January, Glover said Juncker refused to meet with her and discuss her role.
“They did not want to hear from me about what had worked and what had not worked in my role,” Glover said.
Asked if she ever got a meeting or an answer from the executive, she replied, “No, not at all.”